Syncope and structural heart disease: Historical criteria for vasovagal syncope and ventricular tachycardia

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 12, 2010, Pages 1358-1364

  Sheldon, Robert ^a   Hersi, Ahmad ^a   Ritchie, Debbie ^a   Koshman, Mary Lou ^a   Rose, Sarah ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

history; structural heart disease; syncope; tilt table test; vasovagal; ventricular tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FATIGUE; FEMALE; HEADACHE; HEART ARRHYTHMIA; HEART DISEASE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; STRESS; SURVIVAL; SYNCOPE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; SURVIVAL RATE; SYNCOPE, VASOVAGAL; TACHYCARDIA, VENTRICULAR;

EID: 78650105434     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01835.x     Document Type: Article

References (35)

1. Middlekauff H, Stevenson W, Stevenson L, Saxon L,: Syncope in advanced heart failure: High risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993; 21: 110-116.
2. Andrews N, Fogel R, Pelargonio G, Evans J, Prystowsky E,: Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1999; 34: 2023-2030.
3. Knight B, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA,: Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999; 33: 1964-1970.
4. Serletis A, Rose S, Sheldon AG, Sheldon RS,: Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J 2006; 27: 1965-1970.
5. Colman N, Nahm K, Ganzeboom KS, Shen WK, Reitsma J, Linzer M, Wieling W, Kaufmann H,: Epidemiology of reflex syncope. Clin Auton Res 2004; 14 (Suppl 1): 9-17.
6. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Granell RR, Sarasin F, Ungar A, Van Dijk JG, Walma EP, Wieling W, Abe H, Benditt DG, Decker WW, Grubb BP, Kaufmann H, Morillo C, Olshansky B, Parry SW, Sheldon R, Shen WK,; ESC Committee for Practice Guidelines (CPG), Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Auricchio A, Acarturk E, Andreotti F, Asteggiano R, Bauersfeld U, Bellou A, Benetos A, Brandt J, Chung MK, Cortelli P, Da Costa A, Extramiana F, Ferro J, Gorenek B, Hedman A, Hirsch R, Kaliska G, Kenny RA, Kjeldsen KP, Lampert R, Mølgard H, Paju R, Puodziukynas A, Raviele A, Roman P, Scherer M, Schondorf R, Sicari R, Vanbrabant P, Wolpert C, Zamorano JL,: Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J 2009; 30: 2631-2671.
7. Sheldon RS,: Tilt testing for syncope: A reappraisal. Curr Opin Cardiol 2005; 20: 38-41.
8. Hsia HH, Marchlinski FE,: Electrophysiology studies in patients with dilated cardiomyopathies. Card Electrophysiol Rev 2002; 6: 472-481.
9. Mittal S, Iwai S, Stein K, Markowitz S, Slotwiner D, Lerman B,: Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999; 34: 1082-1089.
10. Pires L, May L, Ravi S, Parry T, Lal V, Nino C,: Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter defibrillator. Am J Cardiol 2000; 85: 725-728.
11. Van Donselaar CA, Geerts AT, Meulstee J, Habbema JDF, Staal A,: Reliability of the diagnosis of a first seizure. Neurology 1989; 39: 267-271.
12. Sheldon R, Rose S, Ritchie, Connolly SJ, Koshman M, Lee MA, Frenneaux M, Fisher M, Murphy W,: Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol 2002; 40: 142-148.
13. Sheldon R, Rose S, Connolly SJ, Ritchie D, Koshman M, Frenneaux M, for the Syncope Symptom Study Investigators: Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 2006; 27: 344-350.
14. Calkins H, Shyr Y, Frumin H, Schork A, Morady F,: The value of the clinical history in differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med 1995; 98: 365-373.
15. Alboni P, Brignole M, Menozzi C, Raviele A, Del Rosso A, Dinelli M, Solano A, Bottoni N,: Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Card 2001; 37: 1921-1928.
16. Martin TP, Hanusa BH, Kapoor WN,: Risk stratification of patients with syncope. Ann Emerg Med 1997; 29: 459-466.
17. Oh JH, Hanusa BH, Kapoor WN,: Do symptoms predict cardiac arrhythmias and mortality in patients with syncope? Arch Int Med 1999; 159: 375-380.
18. Sheldon RS, Killam S,: Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 1992; 19: 773-779.
19. Sheldon RS, Koshman ML,: A randomized study of tilt test angle in patients with undiagnosed syncope. Can J Cardiol 2001; 17: 1051-1057.
20. Hinkle LE Jr, Thaler HT,: Clinical classification of cardiac deaths. Circulation 1982; 65: 457-464.
21. Bloch DA, Moses LE, Michel BA,: Statistical approaches to classification. Methods for developing classification and other criteria rules. Arth Rheum 1990; 33: 1137-1144.
22. Metz CE,: Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-298.
23. Sheldon RS, Sheldon AG, Connolly SJ, Morillo CA, Klingenheben T, Krahn AD, Koshman ML, Ritchie D,: Age of first faint in patients with vasovagal syncope. J Cardiovasc Electrophysiol 2006; 17: 49-54.
24. Calkins H, Byrne M, El-Atassi R, Kalbfleisch S, Langberg JJ, Morady F,: The economic burden of unrecognized vasodepressor syncope. Am J Med 1993; 95: 473-479.
25. Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC,: Cost implications of testing strategy in patients with syncope: Randomized assessment of syncope trial. J Am Coll Cardiol 2003; 42: 495-501.
26. Steinberg LA,: Syncope in children: Diagnostic tests have a high cost and low yield. J Pediatr 2005; 146: 355-358.
27. Barón-Esquivias G, Moreno SG, Martinez A, Pedrote A, Vazquez F, Granados C, Bollain E, Lage E, De La Llera LD, Rodriguez MJ, Errazquin F, Burgos J,: Cost of diagnosis and treatment of syncope in patients admitted to a cardiology unit. Europace 2006; 8: 122-127.
28. Farwell DJ, Sulke AN,: Does the use of a syncope diagnostic protocol improve the investigation and management of syncope? Heart 2004; 90: 52-58.
29. Reed MJ, Newby DE, Coull AJ, Jacques KG, Prescott RJ, Gray AJ,: The risk stratification of syncope in the emergency department (ROSE) pilot study: A comparison of existing syncope guidelines. Emerg Med J 2007; 24: 270-275.
30. Quinn JV, Stiell IG, Sellers KL, Kohn MA, Wells GA,: Derivation of the San Franscico Syncope Rule to predict patients with short-term serious outcomes. Ann Emerg Med 2004; 43: 224-232.
31. Del Rosso A, Ungar A, Maggi R, Giada F, Petix NR, De Santo T, Menozzi C, Brignole M,: Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: The EGSYS score. Heart 2008; 94: 1620-1626.
32. Sneddon JF, Scalia G, Ward DE, McKenna WJ, Camm AJ, Frenneaux MP,: Exercise induced vasodepressor syncope. Br Heart J 1994; 71: 554-557.
33. Sakaguchi S, Shultz JJ, Remole SC, Adler SW, Lurie KG, Benditt DG,: Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol 1995; 75: 476-478.
34. Mittal S, Hao SC, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB,: Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol 2001; 38: 371-376.
35. Olshansky B, Poole JE, Johnson G, Anderson J, Hellkamp AS, Packer D, Mark D, Lee KL, Bardy GH, for the SCD-HeFT Investigators: Syncope predicts the outcome of cardiomyopathy patients. Analysis of the SCD-HeFT Study. J Am Coll Cardiol 2008; 51: 1277-1282.